• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSPHERE MEDICAL S.A. EMBOSPHERE; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSPHERE MEDICAL S.A. EMBOSPHERE; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Catalog Number S020GH
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Vomiting (2144); Dyskinesia (2363); Neck Pain (2433); Voice alteration (4906)
Date of Event 01/08/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This event was identified during internal quality system activities involving retrospective review of literature sources.Upon review, the manufacturer determined the event meets applicable medical device reporting criteria and is submitting this report to ensure completeness of complaint and mdr documentation.This submission does not represent new information regarding device performance or a change in the known risk profile of the device.The suspect device was not returned for evaluation.Device lot information was not available from the publication; therefore, a review of manufacturing records and complaint trending specific to the device lot could not be performed.Based on the information available from the literature source, the complaint could not be confirmed, and a definitive root cause could not be determined.
 
Event or Problem Description
Study: cheng, k.-l., liang, k.-w., lee, h.-l., wang, h.-y., & shen, c.-y.(2023).Thyroid artery embolization of large solitary symptomatic benign thyroid nodules through transradial approach.Quantitative imaging in medicine and surgery, 13(8), 5355-5361.Https://doi.Org/10.21037/qims-22-1385 was reviewed during internal quality system activities.The publication describes the efficacy and safety of transradial access (tra) thyroid artery embolization (tae) for patients with large solitary symptomatic benign thyroid nodules.This literature article describes multiple patient events.The study alleges the microspheres used in thyroid artery embolization (tae) procedures have been associated with radial artery spasm, pain, vomiting, voice change, and neck pain.30 f radial artery spasm, pain.Intraprocedural complication with radial artery spasm was observed during catheterization, which resolved with administration of intra-arterial calcium channel blocker.42 m received oma for neck pain resolved after oral mefenamic acid treatment.No overt or subclinical hyperthyroidism and no major complications were noted.23 m neck pain and steroids for hoarseness occurred within 1 week after the procedure and resolved with conservative treatment.Experienced considerable hoarseness following tae that resolved after oral corticosteroid treatment for 7 days.33 f received oma for neck pain and vomiting resolved after oral mefenamic acid treatment.No overt or subclinical hyperthyroidism and no major complications were noted.Periprocedural complication with temporary vomiting, no neurologic symptoms or blurred vision were noted periprocedural complication with temporary vomiting.45 f neck pain resolved after oral mefenamic acid treatment.All patients were discharged on the same day.No overt or subclinical hyperthyroidism and no major complications were noted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOSPHERE
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
BIOSPHERE MEDICAL S.A.
parc des nations paris nord 2
383 rue de la belle etoile
roissy-en-france, 95700
FR  95700
Manufacturer (Section G)
BIOSPHERE MEDICAL S.A.
parc des nations paris nord 2
383 rue de la belle etoile
roissy-en-france, 95700
FR   95700
Manufacturer Contact
marie-laure patucca
parc des nations paris nord 2
383 rue de la belle etoile
roissy-en-france, 95700
FR   95700
MDR Report Key25798652
Report Number9615728-2026-00090
Device Sequence Number14925030
Product Code KRD
UDI-Device Identifier00884450402948
UDI-Public00884450402948
Combination Product (Y/N)N
Initial Reporter StateUT
Initial Reporter CountryUS
PMA/510(K) Number
K181300
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Literature,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 07/13/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberS020GH
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/08/2024
Initial Report FDA Received Date07/13/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Usage of Device Unknown
Patient Sequence Number1
Patient SexUnknown
-
-